Menarini Group Partners with VisualDx to Enhance BPDCN Identification Using AI/ML Tools
Italy’s Menarini Group, through its subsidiary Stemline Therapeutics Inc., has formed a partnership with US-based...
Stemline Therapeutics
Menarini Group Expands Oncology Pipeline with Insilico Medicine License
Italy’s Menarini Group, through its subsidiary Stemline Therapeutics Inc., has entered into a licensing deal...
Menarini’s Stemline Signs $500M+ License with Insilico for Cancer Drug Candidate
Italy’s Menarini Group, through its subsidiary Stemline Therapeutics, has entered an exclusive license agreement with...